ASP Isotopes Inc. is a development stage advanced materials company. The Company is engaged in the development of technology and processes to produce isotopes for use in multiple industries. The Company employs proprietary technology, the Aerodynamic Separation Process (ASP technology). Its initial focus is on producing and commercializing highly enriched isotopes for the healthcare and technology industries. Its Nuclear Fuels segment is focused on research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market. Its Specialist Isotopes and Related Services segment is focused on research and development of technologies and methods used to separate high-value, low-volume isotopes (such as C-14, Mo-100, and Si-28) for highly specialized target end markets other than advanced nuclear fuels, including pharmaceuticals and agrochemicals, nuclear medical imaging, and others.
종목 코드 ASPI
회사 이름ASP Isotopes Inc
상장일Nov 10, 2022
CEOMr. Paul Elliot Mann
직원 수136
유형Ordinary Share
회계 연도 종료Nov 10
주소601 Pennsylvania Avenue Nw
도시WASHINGTON
증권 거래소NASDAQ Capital Market Consolidated
국가United States of America
우편 번호20004
전화12027562245
웹사이트https://aspisotopes.com/
종목 코드 ASPI
상장일Nov 10, 2022
CEOMr. Paul Elliot Mann
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음